Arkolith/Insider Trading/AUPH/Form 4

Tang Kevin

DirectorAurinia Pharmaceuticals Inc. (AUPH) · full profile →Form 4 · filed Aug 5, 2025
Net Buying
Open-Market Buys
$13.6M
Open-Market Sells
$0
Net Open-Market Flow
$13.6M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 5, 2025Buy(P)200K$11.68$2.3M11.3M
Aug 4, 2025Buy(P)100K$11.34$1.1M11.1M
Aug 1, 2025Buy(P)1.0M$10.12$10.1M11.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-021066) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML